Molecular etiology and pathogenesis of hereditary cardiomyopathy.
about
Recent advances in genetic testing and counseling for inherited arrhythmiasAblation of the cardiac-specific gene leucine-rich repeat containing 10 (Lrrc10) results in dilated cardiomyopathyCardiomyopathy in α-kinase 3 (ALPK3)-deficient micePrioritizing causal disease genes using unbiased genomic featuresNew population-based exome data are questioning the pathogenicity of previously cardiomyopathy-associated genetic variants.Rescue of familial cardiomyopathies by modifications at the level of sarcomere and Ca2+ fluxes.Phospholamban C-terminal residues are critical determinants of the structure and function of the calcium ATPase regulatory complex.DOT1L regulates dystrophin expression and is critical for cardiac function.Autosomal recessive transmission of MYBPC3 mutation results in malignant phenotype of hypertrophic cardiomyopathy.A Novel Mutation in the CYP11B1 Gene Causes Steroid 11β-Hydroxylase Deficient Congenital Adrenal Hyperplasia with Reversible Cardiomyopathy.New and TALENted genome engineering toolbox.Molecular basis of hereditary cardiomyopathy: abnormalities in calcium sensitivity, stretch response, stress response and beyond.The diverse functions of Dot1 and H3K79 methylation.Current treatment options in (peri)myocarditis and inflammatory cardiomyopathy.Standard and etiology-directed evidence-based therapies in myocarditis: state of the art and future perspectives.Modeling GATAD1-Associated Dilated Cardiomyopathy in Adult Zebrafish.Echocardiographic characterization of hypertrophic cardiomyopathy in Chinese patients with myosin-binding protein C3 mutations.Disruptor of telomeric silencing 1-like (DOT1L): disclosing a new class of non-nucleoside inhibitors by means of ligand-based and structure-based approaches.
P2860
Q28074154-834D5577-F4DE-4F70-B801-606C198C2DAAQ28512007-C7C7C45F-5B55-48C8-98C6-D6AE0C109007Q28589708-16B922A5-3D0D-4040-AF48-01A6318A9B1BQ28652887-7C455BBD-D370-4D79-ABB6-EE652201BC40Q30585171-064066B4-DDFF-4343-AB33-F4653FB29C8CQ33787794-5CAFAD5A-E04D-442A-B7D3-1AA81263B161Q34170810-DB55065A-6AF6-4105-A770-F7194B25CE1EQ34557154-134E43E5-3F65-4FAE-AAFD-4CEC7A1026E7Q34806455-503F4CE8-8683-49CD-B8B7-A522DF13B2DCQ35918738-4BA9D567-950E-4D0D-AD85-DC7070CD4AAEQ37662636-EEF029DE-B303-4574-A1BB-7C4233AA6E1FQ37675919-6846FE93-B0D2-4492-B59E-AC9239647FE3Q37897061-C246D21E-E299-4AA3-8C51-9C29D665232EQ38045203-B85914D7-916A-4088-B0E9-1F4D090B1392Q38066111-F55ADF2D-19D0-4E15-A867-1DCD14756CE0Q41692598-60CB38E2-755A-4327-80E0-F5850477AE1EQ42290649-7DB0AD92-3088-4574-BD11-B59FAE0AD94BQ48238825-3E0861A0-0D06-4E5F-B824-CE53D3C6E9C2
P2860
Molecular etiology and pathogenesis of hereditary cardiomyopathy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 04 September 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Molecular etiology and pathogenesis of hereditary cardiomyopathy.
@en
Molecular etiology and pathogenesis of hereditary cardiomyopathy.
@nl
type
label
Molecular etiology and pathogenesis of hereditary cardiomyopathy.
@en
Molecular etiology and pathogenesis of hereditary cardiomyopathy.
@nl
prefLabel
Molecular etiology and pathogenesis of hereditary cardiomyopathy.
@en
Molecular etiology and pathogenesis of hereditary cardiomyopathy.
@nl
P356
P1433
P1476
Molecular etiology and pathogenesis of hereditary cardiomyopathy.
@en
P2093
Akinori Kimura
P304
P356
10.1253/CIRCJ.CJ-08-0050
P478
72 Suppl A
P577
2008-09-04T00:00:00Z